Optimal Amount of Zinc to Include in a Lipid-based Nutrient Supplement (LNS)
Malnutrition
About this trial
This is an interventional prevention trial for Malnutrition focused on measuring point-of-use fortification, zinc supplement, lipid-based nutrient supplement, zinc deficiency, micronutrient deficiency, anemia
Eligibility Criteria
Inclusion Criteria:
- 9.0 to 9.9 mo of age
Exclusion Criteria:
- severe anemia
- severely malnourished
- presence of bipedal oedema
- severe illness
- congenital abnormalities
- chronic medical condition
- known HIV infection of mother or infant
- history of peanut allergy
- history of anaphylaxis or serious allergic reaction to any substance
Sites / Locations
- Institut de Recherche en Sciences de la Sante
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Experimental
Experimental
Placebo Comparator
Experimental
No Intervention
LNS-Zn5
LNS-Zn10
LNS-Zn0
Suppl-Zn5
Delayed intervention group
Daily intake of 20 g LNS containing 5 mg of zinc and a daily placebo supplement
Daily intake of 20 g LNS containing 10 mg of zinc and a daily placebo supplement
Daily intake of 20 g LNS containing 0 mg of zinc and a daily placebo supplement
Daily intake of zinc supplement containing 5 mg of zinc and 20 g LNS containing 0 mg of zinc
Standard care from age 8 to 18 months. Daily consumption of LNS from age 18 to 28 months.